Disposition of 882 shares by John Kim of Cognizant Technology subject to Rule 16b-3
| 950130 Stock | KRW 10,450 1,380 0.27% |
About 62% of Access Bio's investor base is looking to short. The analysis of current outlook of investing in Access Bio suggests that many traders are alarmed regarding Access Bio's prospects. Access Bio's investor sentiment overview provides quick insight into current market opportunities from investing in Access Bio. The current market sentiment, together with Access Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Access Bio stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Access Bio stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Access daily returns and investor perception about the current price of Access Bio as well as its diversification or hedging effects on your existing portfolios.
Access |
Filed transaction by Cognizant Technology Solutions Officer: Evp, Clo, Cao. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Access Bio Fundamental Analysis
We analyze Access Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Access Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Access Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Access Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Access Bio stock to make a market-neutral strategy. Peer analysis of Access Bio could also be used in its relative valuation, which is a method of valuing Access Bio by comparing valuation metrics with similar companies.
Peers
Access Bio Related Equities
| 035510 | Shinsegae Information | 1.92 | ||||
| 230360 | Echomarketing CoLtd | 0.85 | ||||
| 017670 | SK Telecom | 0.58 | ||||
| 014570 | Korean Drug | 0.50 | ||||
| 035460 | Kisan Telecom | 0.65 | ||||
| 025770 | Korea Information | 0.81 | ||||
| 002450 | Samick Musical | 2.23 |
Check out Access Bio Hype Analysis, Access Bio Correlation and Access Bio Performance. Note that the Access Bio information on this page should be used as a complementary analysis to other Access Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Access Stock analysis
When running Access Bio's price analysis, check to measure Access Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Access Bio is operating at the current time. Most of Access Bio's value examination focuses on studying past and present price action to predict the probability of Access Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Access Bio's price. Additionally, you may evaluate how the addition of Access Bio to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |